HEALWELL Gives Notice of Imminent Exercise of Call Option by WELL Health
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) announced that WELL Health Technologies Corp. plans to exercise its call option to acquire 61.6 million shares (30.8M Class A and 30.8M Class B) from existing shareholders. This action coincides with HEALWELL's acquisition of Orion Health Holdings , expected to complete on April 1, 2025.
Following the Orion Health acquisition, HEALWELL will have approximately 261.5 million Class A shares outstanding. After exercising the call option, WELL will own about 37.3% of economic interest and 69.6% of voting rights in HEALWELL. The deal grants WELL the ability to nominate a majority of HEALWELL's Board of Directors.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ha annunciato che WELL Health Technologies Corp. prevede di esercitare la sua opzione di acquisto per acquisire 61,6 milioni di azioni (30,8 milioni di Classe A e 30,8 milioni di Classe B) da azionisti esistenti. Questa azione coincide con l'acquisizione da parte di HEALWELL di Orion Health Holdings, che si prevede si completerà il 1 aprile 2025.
Dopo l'acquisizione di Orion Health, HEALWELL avrà circa 261,5 milioni di azioni di Classe A in circolazione. Dopo aver esercitato l'opzione di acquisto, WELL possiederà circa 37,3% di interesse economico e 69,6% di diritti di voto in HEALWELL. L'accordo consente a WELL di nominare la maggioranza del Consiglio di Amministrazione di HEALWELL.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) anunció que WELL Health Technologies Corp. planea ejercer su opción de compra para adquirir 61.6 millones de acciones (30.8 millones de Clase A y 30.8 millones de Clase B) de accionistas existentes. Esta acción coincide con la adquisición de HEALWELL de Orion Health Holdings, que se espera se complete el 1 de abril de 2025.
Tras la adquisición de Orion Health, HEALWELL tendrá aproximadamente 261.5 millones de acciones de Clase A en circulación. Después de ejercer la opción de compra, WELL poseerá alrededor del 37.3% de interés económico y el 69.6% de derechos de voto en HEALWELL. El acuerdo otorga a WELL la capacidad de nombrar a la mayoría de la Junta Directiva de HEALWELL.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF)는 WELL Health Technologies Corp.가 기존 주주로부터 6,160만 주 (3,080만 주 클래스 A 및 3,080만 주 클래스 B)를 인수하기 위한 콜 옵션을 행사할 계획이라고 발표했습니다. 이 조치는 HEALWELL의 Orion Health Holdings 인수와 일치하며, 이는 2025년 4월 1일에 완료될 것으로 예상됩니다.
Orion Health 인수 후, HEALWELL은 약 2억 6,150만 클래스 A 주식이 발행될 것입니다. 콜 옵션을 행사한 후, WELL은 HEALWELL에서 약 37.3%의 경제적 이익과 69.6%의 의결권을 보유하게 됩니다. 이 거래는 WELL이 HEALWELL의 이사회를 다수 추천할 수 있는 권한을 부여합니다.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) a annoncé que WELL Health Technologies Corp. prévoit d'exercer son option d'achat pour acquérir 61,6 millions d'actions (30,8 millions de Classe A et 30,8 millions de Classe B) auprès des actionnaires existants. Cette action coïncide avec l'acquisition par HEALWELL de Orion Health Holdings, dont l'achèvement est prévu pour le 1er avril 2025.
Suite à l'acquisition d'Orion Health, HEALWELL disposera d'environ 261,5 millions d'actions de Classe A en circulation. Après avoir exercé l'option d'achat, WELL possédera environ 37,3% d'intérêt économique et 69,6% de droits de vote dans HEALWELL. L'accord permet à WELL de nommer la majorité du Conseil d'Administration de HEALWELL.
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) gab bekannt, dass WELL Health Technologies Corp. plant, seine Kaufoption auszuüben, um 61,6 Millionen Aktien (30,8 Millionen Klasse A und 30,8 Millionen Klasse B) von bestehenden Aktionären zu erwerben. Diese Maßnahme fällt mit der Übernahme von Orion Health Holdings durch HEALWELL zusammen, die voraussichtlich am 1. April 2025 abgeschlossen wird.
Nach der Übernahme von Orion Health wird HEALWELL etwa 261,5 Millionen ausstehende Klasse A Aktien haben. Nach Ausübung der Kaufoption wird WELL etwa 37,3% wirtschaftliches Interesse und 69,6% Stimmrechte an HEALWELL besitzen. Der Deal gewährt WELL die Möglichkeit, die Mehrheit des Vorstands von HEALWELL zu benennen.
- Strategic acquisition by WELL Health increases stability and backing
- Concurrent completion of Orion Health acquisition expands business operations
- Significant voting control (69.6%) transferred to WELL Health
- Existing shareholders' influence diluted with WELL gaining board control
Toronto, Ontario--(Newsfile Corp. - March 31, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, announced today that it understands WELL Health Technologies Corp. ("WELL") intends to exercise its right to acquire 30,800,000 Class A Subordinate Voting Shares ("SVS") and 30,800,000 Class B Multiple Voting Shares ("MVS") of the Company from certain of its existing shareholders (the "Call Right") pursuant to the call option agreement between HEALWELL, WELL, certain founding shareholders of HEALWELL and their permitted transferees dated October 1, 2023 (the "Call Option Agreement").
The Call Right is expected to be exercised concurrently with the closing of the acquisition by the Company of Orion Health Holdings Limited ("Orion Health"), which is anticipated to be completed on April 1, 2025. The parties intend to enter into an amendment to the Call Option Agreement on the same date to facilitate and streamline the mechanics of the exercise of the Call Right.
Exercise of the Call Right
It is anticipated that HEALWELL will have approximately 261,547,371 SVSs issued and outstanding on HEALWELL's acquisition of Orion Health, following the issuance of 35,643,478 SVSs to the vendor in the Orion Health acquisition, 12,737,500 SVSs in connection with the conversion of 12,737,500 subscription receipts as part of the
Under the previously disclosed investor rights agreement between HEALWELL and WELL dated October 1, 2023 (the "Investor Rights Agreement"), upon the exercise of the Call Right, WELL will also have the ability to nominate a majority of the directors to the Board of Directors of the Company.
Additional Information
WELL was approved as a control person of HEALWELL by resolutions of the shareholders of HEALWELL, on a disinterested basis, on September 21, 2023. The TSX subsequently approved WELL as a control person of HEALWELL on October 6, 2023.
Additional information with respect to the Call Option Agreement and the Investor Rights Agreement and their material terms can be found in HEALWELL's Notice of Meeting and Management Information Circular dated August 21, 2023, which is available under the Company's profile on SEDAR+ at www.sedarplus.ca. Additional information on WELL's intention to exercise the Call Right and its anticipated ownership and control of the Company are set out in WELL's press release issued today and available under WELL's profile on SEDAR+ at www.sedarplus.ca.
Dr. Alexander Dobranowski
Chief Executive Officer
HEALWELL AI Inc.
About HEALWELL AI
HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol "AIDX" and on the OTC Exchange under the symbol "HWAIF". To learn more about HEALWELL, please visit https://healwell.ai/.
Forward-Looking Statements
Certain statements in this press release, constitute "forward-looking information" and "forward looking statements" (collectively, "forward looking statements") within the meaning of applicable Canadian securities laws, including statements about the Company's anticipated acquisition of Orion Health; the anticipated timing of completing the acquisition of Orion Health; the anticipated amendment of the Call Option Agreement and exercise of the Call Right by WELL; and the Company's anticipated issued and outstanding securities following completion of the Orion Health acquisition; and are based on assumptions, expectations, estimates and projections as of the date of this press release. Forward-looking statements are often, but not always, identified by words or phrases such as "expect", "intend", "anticipate" or variations of such words and phrases or statements that certain future conditions, actions, events or results "will", "may", "could", "would", "should", "might" or "can" be taken, occur or be achieved, or the negative of any of these terms . Forward-looking statements are necessarily based upon management's perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by HEALWELL as of the date of such statements, are outside of HEALWELL's control and are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being entirely or partially incorrect or untrue. Forward looking statements contained in this press release are based on various assumptions, including, but not limited to, the following: the Company's ability to satisfy any remaining conditions precedent to completion of the Orion acquisition; HEALWELL's ability to complete the acquisition on the timelines and terms contemplated; WELL's ability to satisfy any remaining conditions to exercising its Call Right; WELL's ability to complete the exercise of the Call Right on the timelines and terms contemplated; the potential exercise or conversion of outstanding warrants, equity incentives and other securities convertible into securities of HEALWELL; the stability of general economic and market conditions; HEALWELL's ability to comply with applicable laws and regulations; and that the risk factors noted below, collectively, do not have a material impact on HEALWELL's business, operations, revenues and/or results. By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections, or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved.
Known and unknown risk factors, many of which are beyond the control of HEALWELL, could cause the actual results of HEALWELL to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled "Risk Factors" in HEALWELL's most recent annual information form dated April 1, 2024, which is available under HEALWELL's SEDAR+ profile at www.sedarplus.ca. The risk factors are not intended to represent a complete list of the factors that could affect HEALWELL and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management's expectations and plans relating to the future. HEALWELL disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements.
For more information:
Pardeep S. Sangha
Investor Relations, HEALWELL AI Inc.
Phone: 604-572-6392
ir@healwell.ai
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/246696